ER Negative Breast Cancer and miRNA: There Is More to Decipher Than What the Pathologist Can See!

Breast cancer (BC), the most prevalent cancer in women, is a heterogenous disease. Despite advancements in BC diagnosis, prognosis, and therapeutics, survival rates have drastically decreased in the metastatic setting. Therefore, BC still remains a medical challenge. The evolution of high-throughput...

Descripción completa

Detalles Bibliográficos
Autores principales: Chamandi, Ghada, El-Hajjar, Layal, El Kurdi, Abdallah, Le Bras, Morgane, Nasr, Rihab, Lehmann-Che, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452617/
https://www.ncbi.nlm.nih.gov/pubmed/37626796
http://dx.doi.org/10.3390/biomedicines11082300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452617/
https://www.ncbi.nlm.nih.gov/pubmed/37626796
http://dx.doi.org/10.3390/biomedicines11082300

Ejemplares similares